Renaissance Technologies
PMI

Renaissance Technologies’s Picard Medical PMI Stock Holding History

Renaissance Technologies’s Portfolio PMI Stock Details PMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.2K Buy
+3,448
New +$73.3K ﹤0.01% 3078

Other funds holding PMI

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $95.2B AUM 32.92% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
PCA
Pallas Capital Advisors Braintree, Massachusetts $3.25B AUM 40.07% 1-Year Est. Return
WMP
Wealth Management Partners Tucson, Arizona $425M AUM 60.71% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return

Renaissance Technologies's PMI Position: Q2 2026 in Review

Renaissance Technologies opened a new position in Picard Medical (PMI) in Q2 2026: 3,448 shares worth $28.2K. The stake represents ﹤0.01% of the portfolio and ranks #3078 among its holdings.

34 funds tracked by Wall St. Rank hold PMI as of Q2 2026.

  • Renaissance Technologies held 3,448 shares of Picard Medical worth $28.2K as of Q2 2026.
  • Picard Medical was a new Renaissance Technologies position in Q2 2026.
  • Picard Medical made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #3078 holding.
  • 34 funds tracked by Wall St. Rank held Picard Medical as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.